Serum biomarker gMS-Classifier2: predicting conversion to clinically definite multiple sclerosis.

por Georgina Arrambide, Carmen Espejo, Jennifer Yarden, Ella Fire, Larissa Spector, Nir Dotan, Avinoam Dukler, Alex Rovira, Xavier Montalban, Mar Tintore
Publicado 2013

Risk acceptance in multiple sclerosis patients on natalizumab treatment.

por Carmen Tur, Mar Tintoré, Ángela Vidal-Jordana, Denis Bichuetti, Pablo Nieto González, María Jesús Arévalo, Georgina Arrambide, Elisenda Anglada, Ingrid Galán, Joaquín Castilló, Carlos Nos, Jordi Río, María Isabel Martín, Manuel Comabella, Jaume Sastre-Garriga, Xavier Montalban
Publicado 2013